Skip to Content
Merck
  • Anti-inflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice.

Anti-inflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice.

Life sciences (2014-01-10)
Purum Kang, Ka Young Kim, Hui Su Lee, Sun Seek Min, Geun Hee Seol
ABSTRACT

Anethole, the major component of the essential oil of star anise, has been reported to have antioxidant, antibacterial, antifungal, anti-inflammatory, and anesthetic properties. In this study, we investigated the anti-inflammatory effects of anethole in a mouse model of acute lung injury induced by lipopolysaccharide (LPS). BALB/C mice were intraperitoneally administered anethole (62.5, 125, 250, or 500 mg/kg) 1 h before intratracheal treatment with LPS (1.5 mg/kg) and sacrificed after 4 h. The anti-inflammatory effects of anethole were assessed by measuring total protein and cell levels and inflammatory mediator production and by histological evaluation and Western blot analysis. LPS significantly increased total protein levels; numbers of total cells, including macrophages and neutrophils; and the production of inflammatory mediators such as matrix metalloproteinase 9 (MMP-9), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and nitric oxide (NO) in bronchoalveolar lavage fluid. Anethole (250 mg/kg) decreased total protein concentrations; numbers of inflammatory cells, including neutrophils and macrophages; and the inflammatory mediators MMP-9, TNF-α and NO. In addition, pretreatment with anethole decreased LPS-induced histopathological changes. The anti-inflammatory mechanism of anethole in LPS-induced acute lung injury was assessed by investigating the effects of anethole on NF-κB activation. Anethole suppressed the activation of NF-κB by blocking IκB-α degradation. These results, showing that anethole prevents LPS-induced acute lung inflammation in mice, suggest that anethole may be therapeutically effective in inflammatory conditions in humans.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Lactic Dehydrogenase from bovine heart, 1000 units/mL
Supelco
trans-Anethole, analytical standard
Sigma-Aldrich
trans-Anethole, 99%
Sigma-Aldrich
trans-Anethole, ≥99%, FCC, FG
Sigma-Aldrich
L-Lactic Dehydrogenase from bovine muscle, Type X, ammonium sulfate suspension, ≥600 units/mg protein
Sigma-Aldrich
L-Lactic Dehydrogenase from bovine heart, Type XVII, buffered aqueous glycerol solution, ≥400 units/mg protein
Sigma-Aldrich
L-Lactic Dehydrogenase from porcine heart, ammonium sulfate suspension, ≥200 units/mg protein
Sigma-Aldrich
L-Lactic Dehydrogenase from bovine heart, Type III, ammonium sulfate suspension, ≥500 units/mg protein
Sigma-Aldrich
Lactic Dehydrogenase, recombinant from E. coli, ≥90 U/mg
Supelco
trans-Anethole, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Lactic Dehydrogenase from rabbit muscle, Type XI, lyophilized powder, 600-1,200 units/mg protein
Sigma-Aldrich
L-Lactic Dehydrogenase from rabbit muscle, Type II, ammonium sulfate suspension, 800-1,200 units/mg protein